📰 Nasdaq Morf News
Page 2 - Nasdaq Morf News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Morf. Real-time updates on events, politics, business and more.
October 13, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price […]
September 26, 2023
WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Morphic Holdings Inc. (Nasdaq: MORF) today announced that Chief Executive Officer Dr. Praveen...
September 25, 2023
Morphic (NASDAQ:MORF – Get Free Report) had its target price lowered by analysts at Stifel Nicolaus from $61.00 to $33.00 in a report released on Monday, Briefing.com reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ target price points to a potential upside of 25.24% from the stock’s previous close. A […]
September 22, 2023
-Orally administered MORF-057 achieved primary endpoint and demonstrates clinically meaningful improvements across secondary and exploratory measures- ...
September 11, 2023
Affinity Asset Advisors LLC decreased its position in shares of Morphic Holding, Inc. (NASDAQ:MORF – Free Report) by 51.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 135,863 shares of the company’s stock after selling 145,058 shares during the quarter. Morphic accounts […]
September 7, 2023
Prosight Management LP reduced its stake in shares of Morphic Holding, Inc. (NASDAQ:MORF – Free Report) by 80.3% during the first quarter, Holdings Channel reports. The institutional investor owned 8,464 shares of the company’s stock after selling 34,485 shares during the period. Prosight Management LP’s holdings in Morphic were worth $319,000 as of its most […]
August 12, 2023
Stifel Nicolaus downgraded shares of Morphic (NASDAQ:MORF – Free Report) from a buy rating to a hold rating in a report published on Tuesday morning, MarketBeat reports. Stifel Nicolaus currently has $61.00 price objective on the stock, down from their previous price objective of $69.00. Several other brokerages have also commented on MORF. TheStreet upgraded […]
August 3, 2023
-Reported positive topline results from EMERALD-1 study of MORF-057 in ulcerative colitis- -Continued enrollment on target in EMERALD-2 Phase 2b trial...
July 9, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Free Report) CEO Praveen P. Tipirneni sold 3,597 shares of Morphic stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $57.04, for a total transaction of $205,172.88. Following the transaction, the chief executive officer now directly owns 13,936 shares in […]
June 10, 2023
Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) General Counsel William Devaul sold 7,756 shares of the company’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $60.05, for a total value of $465,747.80. Following the completion of the transaction, the general counsel now directly owns 13,338 shares […]